VerifiedRx
VerifiedRx
Apr 13, 2021
Expedited drug reviews in the time of COVID-19 (Part 2)
Play • 10 min

The Coronavirus pandemic has put a spotlight on drug supply and the approval process for new medications. In this episode, we will define the different expedited drug approval processes, and take a closer look at how successful these programs are in identifying drug efficacy.

 

Guest speaker:

Steven Lucio, PharmD, BCPS

Senior Principal, Pharmacy Solutions

Vizient

 

Moderator:

Gretchen Brummel, PharmD, BCPS

Pharmacy Executive Director

Vizient Center for Pharmacy Practice Excellence

 

Show Notes:

[01:25] Four mechanisms used by FDA to expedite approval of medications: Fast Track, Breakthrough, Accelerated Approval and Priority Review

[01:54] Fast track and breakthrough help drug developers increase communications with the FDA to make approval process flow smoothly

[02:14] The “Fast Track” designation

[2:42] A “Breakthrough” designation – FDA will talk to you more, give advice  

[3:18] Example of an Accelerated Approval

[4:00] Accelerated Approval looks at a surrogate indicator of a disease state’s ultimate outcome

[4:33] “Priority Review” – FDA reviews drug within six months

[5:19] Three reasons why pharmacists need to be aware of the approval programs

[6:07] Expedited approvals are used for serious diseases

[6:15] Analysis: In 2018, 81% of new molecular entities took advantage of at least one expedited program

[6:38] Drugs that use expedited programs have fewer clinical studies and a smaller profile of how they work

[7:20] Survey: 3/4th physicians didn’t know what Breakthrough Therapy meant

[7:57] Analysis of “Accelerated Approval” between 1992 - 2017

[8:44] Why you should know about the expedited drug approval processes

 

Links | Resources:

JAMA Network: FDA Approval and Regulation of Pharmaceuticals, 1983 – 2018, Click Here

JAMA Network: Physicians’ Knowledge About FDA Approval Standards and Perceptions of the “Breakthrough Therapy” Designation, Click Here

JAMA Network: Assessment of the Clinical Benefit of Cancer Drug Receiving Accelerated Approval, Click Here

 

Subscribe Today!

Apple Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

 

More episodes
Search
Clear search
Close search
Google apps
Main menu